Header Logo

Connection

MICHAEL JAMES OVERMAN to Fibrin Fibrinogen Degradation Products

Back to Details
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Fibrin Fibrinogen Degradation Products.
MICHAEL JAMES OVERMAN
Connection Strength
0.045
Fibrin Fibrinogen Degradation Products
  1. Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study. Cancer Med. 2020 09; 9(17):6196-6204.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.